- /
- Supported exchanges
- / US
- / MENS.NASDAQ
Jyong Biotech Ltd. Ordinary Shares (MENS NASDAQ) stock market data APIs
Jyong Biotech Ltd. Ordinary Shares Financial Data Overview
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Jyong Biotech Ltd. Ordinary Shares (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Jyong Biotech Ltd. Ordinary Shares data using free add-ons & libraries
Get Jyong Biotech Ltd. Ordinary Shares Fundamental Data
Jyong Biotech Ltd. Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -2 507 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Jyong Biotech Ltd. Ordinary Shares Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2025-04-23
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Jyong Biotech Ltd. Ordinary Shares News
New
Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow
Jyong Biotech Ltd. New Taipei City, Taiwan/San Francisco, CA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology c...
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development ...
Catalyst Watch: Santa Claus Effect, M&A votes on Electronic Arts and TrueCar, index shuffling
[Futuristic display screen with a bar graph and colorful spreadsheet financial data] matejmo Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stan...
Jyong Biotech Shares Becomes Oversold (MENS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a te...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.